17.11
+0.86
+(5.29%)
At close: January 13 at 4:00:01 PM EST
17.11
0.00
(0.00%)
After hours: January 13 at 4:01:30 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
10,728.00
-5,743.00
-73,758.00
5,878.00
-52,185.00
Investing Cash Flow
8,170.00
-4,297.00
72,777.00
-80,036.00
47,466.00
Financing Cash Flow
-12,620.00
18,367.00
6,550.00
62,675.00
12,571.00
End Cash Position
51,692.00
32,786.00
24,459.00
18,890.00
30,373.00
Interest Paid Supplemental Data
6,973.00
5,848.00
2,495.00
1,500.00
1,180.00
Capital Expenditure
-370.00
-15,000.00
-450.00
-627.00
-1,262.00
Issuance of Debt
--
19,950.00
19,542.00
--
9,975.00
Free Cash Flow
10,358.00
-20,743.00
-74,208.00
5,251.00
-53,447.00
12/31/2020 - 11/29/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CRIS Curis, Inc.
3.3600
-0.88%
IMCR Immunocore Holdings plc
30.03
-1.22%
KPTI Karyopharm Therapeutics Inc.
0.6728
-6.37%
CTMX CytomX Therapeutics, Inc.
0.8874
+0.83%
PBYI Puma Biotechnology, Inc.
3.0800
-6.95%
VNDA Vanda Pharmaceuticals Inc.
4.5300
-1.52%
LXRX Lexicon Pharmaceuticals, Inc.
0.7058
-7.88%
FDMT 4D Molecular Therapeutics, Inc.
4.7600
-13.77%
AGEN Agenus Inc.
3.1550
+1.28%
ENTA Enanta Pharmaceuticals, Inc.
5.03
-1.18%